In conclusion, inspired by the inherent tumor homing ability and excellent biocompatibility of platelets, we have developed biomimetic nanocomposites to achieve a combination therapy combining photothermal therapy, anti-PD-L1 immunotherapy, and chemical drive. The gene discussed is CD274; the disease is neoplasm.